1. 804PHealth-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN: A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC). (23rd October 2018) Authors: Small, E J; Cella, D; McQuarrie, K; Saad, F; Hadaschik, B A; Graff, J N; Uemura, H; Oudard, S; Yu, M K; Hudgens, S; Lopez-Gitlitz, A; Rooney, B; Morris, M; Smith, M R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗